Bullboard - Stock Discussion Forum Alpha Cognition Inc ACOG

Healthcare Biotechnology

Alpha Cognition Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is engaged in developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer's disease and Cognitive Impairment with mild Traumatic Brain Injury (mTBI). The Company’s pipeline includes ALPHA-1062, ALPHA-0602, and ALPHA-0702 and ALPHA-0802 (GEMs). The Company’s ALPHA-1062... see more

Add To Watchlist

NDAQ:ACOG - Post Discussion

Alpha Cognition Inc > $ACOG.v / $ACOGF

View:

Post by stockpatrol on Dec 30, 2021 4:33pm

$ACOG.v / $ACOGF

$ACOG.v / $ACOGF is a biopharmaceutical company currently in clinical trial for their ALPHA-1062, treating under-served neurodegenerative diseases.

https://www.youtube.com/watch?v=-QQSJNvmUuc&ab_channel=RadiusResearch

Here’s a great video to get acquainted with $ACOG.v they’ve been getting a lot of good press recently and for good reason.

APLHA-1062 potentially proving to be the best in its class with patients 45% of whom cannot have acetylcholinesterase inhibitor (AChEI) drugs due to stomach problems.

“Alpha Cognition is de-risked, late stage, and offers a unique combination of high reward with less-than-usual risk thanks to the well-established AChEI market and our evaluation of its preclinical and clinical data in the context of a 505(b)(2) pathway to approval,” Stellick wrote.

https://www.cantechletter.com/2021/12/three-canadian-biopharma-stocks-for-2022/#

143